Perkins Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Perkins Investment Management's DGX Position: Q1 2017 in Review
Perkins Investment Management reduced its Quest Diagnostics (DGX) stake by 15% in Q1 2017, selling an estimated $66.7K and leaving 4,100 shares worth $403K. The position accounts for 0.01% of the portfolio, ranked #233.
Perkins Investment Management first reported a position in DGX in Q2 2013 and has held it in 11 quarters since. The position peaked at $120M in Q3 2013. 614 funds tracked by Wall St. Rank hold DGX as of Q1 2017.
- Perkins Investment Management held 4,100 shares of Quest Diagnostics worth $403K as of Q1 2017.
- Perkins Investment Management sold 700 Quest Diagnostics shares in Q1 2017, an estimated $66.7K.
- Quest Diagnostics made up 0.01% of Perkins Investment Management's portfolio in Q1 2017, its #233 holding.
- Perkins Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 11 quarters since.
- Perkins Investment Management's Quest Diagnostics position peaked at $120M in Q3 2013.
- 614 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2017.
Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.